Literature DB >> 10931232

Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.

N A Wong1, N J Mayer, S MacKell, H M Gilmour, D J Harrison.   

Abstract

AIMS: To assess whether Ki67 and p53 immunostaining may assist the diagnosis and grading of ulcerative colitis-related dysplasia. METHODS AND
RESULTS: Location of Ki67 staining and location and intensity of p53 staining were assessed in ulcerative colitis (UC) cases showing the features of high-grade dysplasia (HGD, n = 14), low-grade dysplasia (LGD, n = 22), 'indefinite for dysplasia' (n = 12), or regenerative atypia (RA, n = 22). Good intra- and inter-observer reproducibilities were demonstrated in the performance of these assessments. All the dysplasia cases showed extension of Ki67 staining above the basal third of the crypt. Moderate intensity p53 staining was seen in 10/22 RA cases, but strong intensity p53 staining was seen only in cases of dysplasia. All the cases of HGD showed extension of Ki67 and p53 staining above the basal two thirds of the crypt.
CONCLUSIONS: Restriction of Ki67 staining to the basal third of the crypt appears to exclude a diagnosis of dysplasia whereas strong intensity p53 staining suggests a diagnosis of dysplasia. Restriction of Ki67 or p53 staining to the basal two-thirds of the crypt appears to exclude a diagnosis of HGD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931232     DOI: 10.1046/j.1365-2559.2000.00934.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  19 in total

Review 1.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 2.  Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.

Authors:  Marietta Iacucci; T Uraoka; M Fort Gasia; N Yahagi
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

Review 3.  Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.

Authors:  Sigrun Thorsteinsdottir; Thorkell Gudjonsson; Ole Haagen Nielsen; Ben Vainer; Jakob Benedict Seidelin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

4.  Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.

Authors:  Rosa Ana Risques; Lisa A Lai; Cigdem Himmetoglu; Anoosheh Ebaee; Lin Li; Ziding Feng; Mary P Bronner; Bassel Al-Lahham; Kris V Kowdley; Keith D Lindor; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Cancer Res       Date:  2011-03-01       Impact factor: 12.701

5.  Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer.

Authors:  Sabine Tejpar; Robert D Odze
Journal:  Gastrointest Cancer Res       Date:  2009-09

Review 6.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

7.  Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection.

Authors:  Fredrik Petersson; Kurt Borch; Lennart E Franzén
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

8.  Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.

Authors:  Pavel Wohl; Tomas Hucl; Pavel Drastich; David Kamenar; Julius Spicak; Eva Honsova; Eva Sticova; Alena Lodererova; Jan Matous; Martin Hill; Petr Wohl; Milos Kucera
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions.

Authors:  Hirofumi Ueda; Hiroyuki Tanaka; Kazuhito Ichikawa; Michio Itabashi; Shingo Kameoka; Shigehiko Fujii; Natsuko Saito; Ryusuke Kimura; Yosuke Shida; Yukari Fujimori; Shinichirou Ohtake; Shigeki Tomita; Johji Imura; Yoshikazu Yasuda; Nobuhiko Tanigawa; Kazuhisa Uchiyama; Takahiro Fujimori
Journal:  Surg Today       Date:  2013-01-10       Impact factor: 2.549

Review 10.  Microscopic features of colorectal neoplasia in inflammatory bowel diseases.

Authors:  Aude Bressenot; Virginie Cahn; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.